Although many medications dont require dose adjustments with GLP-1 therapy, individual circumstances often call for tailored approaches to address specific risks
Cardiovascular Health Support: Aids in heart function and blood circulation, potentially benefiting cardiovascular health
What did it prove and why is it significant for patients in India?The SOUL (semaglutide cardiovascular outcomes) trial showed that oral semaglutides significantly reduced heart attacks, strokes and cardiovascular death in people with type 2 diabetes who were already at high cardiovascular risk
Ostapcuk V, Mohn F, Carl SH, Basters A, Hess D, Iesmantavicius V, et al
Weve taken legal action to protect the American public and our intellectual property and will continue to work with regulators, law enforcement, and other key stakeholders to ensure patients have access to FDA approved safe and effective medicines. Also in February, Novo Nordisk announced approval from the European Commission for a more effective dose of the injectable form of Wegovy
Tirzepatide is considered a next-generation advancement because it acts on two different hormone pathways GLP-1 and GIP (glucose-dependent insulinotropic polypeptide) to provide a more robust approach to metabolic health